Drug on market to be re-evaluated every 5 years

The Korea Food and Drug Administration announced on September 3 that medicines belonging to five therapeutic categories, which was/will be approved within 2013, will be re-evaluated once per year in keeping abreast of the rapid scientific progress.

As for the medicines to be approved after 2013, they will be subject to re-evaluation once every five years. To this end, drug manufacturers shou...